In an earlier publication, we provided evidence that CCL5 treatment promotes the proliferation of MCF-7 human breast cancer cells, through mTOR-dependent mRNA translation of a subset of proteins associated with cell cycle progression and survival [13]. This evidence concerns the gene MTOR and breast cancer.